Methane is not currently approved or marketed as a drug, but it is biologically active and being studied as a potential therapeutic gas. For decades, scientists considered methane completely inert in the body, a waste product of gut bacteria with no physiological effects worth noting. That view has changed significantly. Laboratory and animal research now shows methane has measurable anti-inflammatory, antioxidant, and cell-protective properties, placing it in the same conversation as other therapeutic gases like nitrous oxide and carbon monoxide.
Why Methane Was Considered Inert
Methane is the simplest organic compound: one carbon atom bonded to four hydrogen atoms. It has no color, no smell, and at normal concentrations, no obvious effect on the body. The American Conference of Governmental Industrial Hygienists classifies it as a “simple asphyxiant,” meaning it only becomes dangerous when it displaces enough oxygen to suffocate you. Exposure at 10,000 ppm (1% of the air) has shown no toxic effects. No workplace exposure limit is even recommended because the only real concern is oxygen levels in the room, not methane itself.
That said, there are hints methane isn’t perfectly inert. In one experiment, mice exposed to 70% methane in air fared worse than mice breathing 70% nitrogen, with two of six dying within 18 minutes. Mice in the nitrogen group only developed coordination problems. Under high-pressure conditions, methane also showed mild anesthetic properties in mice. These effects are subtle and only appear at concentrations far beyond anything encountered in medicine or daily life, but they were early clues that methane does interact with living tissue.
How Your Body Makes Methane
Your gut is the main source. Microorganisms called methanogenic archaea, particularly a species called Methanobrevibacter smithii, live in the colon and produce methane as a byproduct of anaerobic metabolism. They reduce carbon dioxide using hydrogen or formate, and the result is methane gas. Not everyone harbors enough of these organisms to produce detectable levels, but in those who do, an estimated 20% to 50% of the methane produced in the gut crosses the intestinal lining into the bloodstream, travels to the lungs, and leaves through exhaled breath.
There may also be a non-microbial source. Emerging data suggest that human cells themselves can generate small amounts of methane under stress, particularly when levels of reactive oxygen species are elevated. This process appears to involve the breakdown of certain sulfur- and nitrogen-containing compounds through reactions driven by free radicals. The amounts are small, but the finding has shifted how researchers think about methane’s role in the body. Some scientists now suggest methane production could be an ancient survival mechanism in cells, linked to the regulation of oxidative stress.
Methane’s Effects Inside the Body
Methane isn’t just passing through. It actively slows down the digestive tract. Animal studies show that methane gas applied directly to intestinal tissue reduced transit by 59% in dogs and decreased the speed of wave-like contractions in guinea pigs. It also increased the strength of contractions in the small intestine across a range of stimulation frequencies. This is one reason methane-producing gut organisms are associated with constipation-predominant conditions.
Beyond the gut, methane appears to protect cells from damage in several ways. It reduces markers of oxidative stress (the kind of chemical damage that occurs when cells are deprived of blood flow and then re-exposed to it). In animal models of liver injury caused by restricted blood flow, inhaled methane preserved the ability of mitochondria, the energy-producing structures inside cells, to function normally. It reduced the release of a protein called cytochrome c, which triggers cell death, and lowered the number of liver cells that died from the injury.
Methane also tamps down inflammation. In studies using saline solutions saturated with dissolved methane, researchers observed reductions in several key inflammatory signals. These anti-inflammatory effects appear to work through a signaling pathway that also boosts the production of anti-inflammatory molecules. The combination of antioxidant, anti-inflammatory, and anti-cell-death properties is what has attracted interest in methane as a potential therapeutic agent.
Where Methane Stands Legally
Under U.S. law, a “medical gas” is defined as a drug that is manufactured or stored in a liquefied, nonliquefied, or cryogenic state and administered as a gas. The list of designated medical gases currently includes oxygen, nitrogen, nitrous oxide, carbon dioxide, helium, carbon monoxide, and medical air. Methane is not on this list. It could theoretically be added if the Secretary of Health and Human Services deemed it appropriate, but that would require investigational drug applications and regulatory review.
So in a strict legal and regulatory sense, methane is not a drug. It is not approved for any therapeutic use in humans. No pharmaceutical company sells methane for medical purposes, and no clinical guidelines recommend it as a treatment.
Research Into Therapeutic Uses
Despite its unofficial status, researchers have been exploring methane’s protective properties in laboratory and animal settings for conditions involving tissue damage from interrupted blood flow (ischemia-reperfusion injury) and excessive inflammation. The two main delivery methods being tested are inhaled methane gas and methane-rich saline, which is normal saline saturated with dissolved methane under high pressure, reaching concentrations of roughly 1.2 to 1.5 millimoles per liter.
Because methane is a small, nonpolar molecule, it moves easily through biological membranes. When inhaled, it crosses from the lungs into the bloodstream and distributes rapidly. It can enter cells and even reach mitochondria, where it may influence the structure and function of membrane proteins by dissolving in the fatty layers of cell membranes. This ease of distribution is part of what makes it an appealing candidate for protecting organs during events like surgery or trauma, where blood flow is temporarily cut off. In one animal study, methane-rich saline was tested as a resuscitation fluid for hemorrhagic shock, with researchers infusing it alongside the animal’s own collected blood to restore blood pressure.
All of this work remains preclinical. No human clinical trials have established methane as a safe and effective treatment for any condition.
Methane in Diagnosis
Where methane does play a recognized role in medicine is as a diagnostic marker. Breath testing for methane is used to identify intestinal methanogen overgrowth, a condition linked to bloating, constipation, and irritable bowel syndrome. The North American Consensus criteria classify a patient as “methane-positive” if any breath sample during testing reaches 10 ppm or higher. However, research on a large dataset of over 12,000 patients found that a simpler baseline reading of 5 ppm or higher could identify methane-positive individuals with 96% sensitivity and nearly 100% specificity. Some analyses suggest the optimal cutoff could be as low as 4 ppm.
This diagnostic use highlights an interesting duality. Methane produced by gut organisms is associated with slower digestion and gastrointestinal symptoms, while externally administered methane shows protective effects in injured tissues. The gas itself is the same molecule, but context, concentration, and location determine whether its effects are helpful or problematic.